Clinical Trial Update: Study Evaluating Venlafaxine ER in Recurrent Depression [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study evaluating venlafaxine extended-release for recurrent major depressive disorder, with the trial status shown as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder Recurrent

Drugs mentioned

• Venlafaxine ER (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major, Recurrence | Phase 4 | Status: COMPLETED